In that regard, the association between reduced (though detectable) ADAMTS-13 levels during remission and ischemic stroke in iTTP survivors [33] suggests that a more stringent control of ADAMTS-13 activity could decrease the risk of ischemic stroke and thereby improve the cognitive status and HRQoL of patients with iTTP. The gene discussed is ADAMTS13; the disease is ischemic stroke.